Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Discover how to use credit card points for hotel stays to save money on your travels. Make your rewards work for you.
22,999 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Velocity closes a $38 million Series A to scale stablecoin-enabled payments for cross-border settlements, backed by a...
A high-profile insider sale can spark questions about a company’s future. This article breaks down the HeartFlow CEO'...
The IRS has boosted standard mileage rates amid rising fuel prices, increasing deductions for business travel and med...
As AI partnerships captivate the market, UiPath shares edged higher amid broader tech weakness. This look at stock ma...
A California court ruling affecting a rival studio triggered a risk-off mood that pulled down entertainment names, in...
Ripple's price failed to clear a midline resistance, prompting renewed debate on whether XRP will break out or resume...
When markets swing, silver investors face tough choices. This article breaks down three clear reasons to consider sel...
A shocking on-stage moment can ripple through a performer's finances. This article breaks down how reportedly used fa...
Rivian’s latest forecast sent a wave through the stock. But should you buy now or wait? This guide breaks down the de...
As 2026 unfolds, the tax on Social Security depends on three numbers, not the payout amount. This guide breaks down h...
Nova Measuring Instruments rode an 80% gain in the past year, but a big insider sale prompts question. This guide bre...